The burden of cardiovascular disease in Asia from 2025 to 2050: a forecast analysis for East Asia, South Asia, South-East Asia, Central Asia, and high-income Asia Pacific regions
Rachel Sze Jen Goh(National University Hospital), Duk‐Woo Park(Ulsan College), Gemma A. Figtree(The University of Sydney), Khung Keong Yeo(SingHealth), Derek J. Hausenloy(University College Hospital), Gwyneth Kong(National University Hospital), Takashi Kajiya(Izumi City General Hospital), Yongcheol Kim(Severance Hospital), Vickram Vijay Anand(Nanyang Technological University), Poay Huan Loh(National University of Singapore), Sarita Rao(Indraprastha Apollo Hospitals), Jonathan Yap(National Heart Centre Singapore), Huay Cheem Tan(National University of Singapore), Shinya Goto(Tokai University), Satoshi Yasuda(National Institute of Health Sciences), Bryan Chong(Ministry of Health), James Yip(National University of Singapore), Gary Tse(Observational & Pragmatic Research Institute), Jack Wei Chieh Tan(National University Heart Centre Singapore), Shir Lynn Lim(National University of Singapore), Lohendran Baskaran(Duke-NUS Medical School), Young‐Hoon Jeong(Chung-Ang University Hospital), Jayanth Jayabaskaran(National University of Singapore), Mark Muthiah(National University of Singapore), Keith Andrew Chan(National University of Singapore), Martin Tze Wah Kueh(University College Dublin), Bryan P. Yan(Chinese University of Hong Kong), Jiong‐Wei Wang(National University of Singapore), Kannan Shankar(National University of Singapore), Ping Chai(National University of Singapore), Chi‐Hang Lee(National University of Singapore), Anurag Mehta(Emory Healthcare), Adrian F. Low(National University of Singapore), Satoshi Honda(National Cerebral and Cardiovascular Center), Roger Foo(Institute of Molecular and Cell Biology), Moo Hyun Kim(Yonsei University), Indah Sukmawati(Pelita Harapan University), Sue Anne Toh(National University of Singapore), Zhong Liang(National University of Singapore), Yi‐Heng Li(National Cheng Kung University Hospital), Henry Li(UNSW Sydney), Siew Pang Chan(National University of Singapore), Silingga Metta Jauhari(National University Heart Centre Singapore), Tiong Cheng Yeo(National University of Singapore), Mamas Mamas(Keele University), Tze‐Fan Chao(National Yang Ming Chiao Tung University), Koo Hui Chan(National University of Singapore), Alan Yean Yip Fong(Sarawak General Hospital), Xin Zhou(Tianjin Medical University General Hospital), Yip Han Chin(Ministry of Health)
Cited by 75
Related Papers
Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction
|New England Journal of Medicine|2015|2k
Rivaroxaban in Patients with a Recent Acute Coronary Syndrome
|New England Journal of Medicine|2011|1.9k
Current State of knowledge on Takotsubo Syndrome: A Position Statement from the Taskforce on Takotsubo Syndrome of the Heart Failure Association of the European Society of Cardiology
|European Journal of Heart Failure|2015|1.2k
Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials
|The Lancet|2019|785
The global burden of metabolic disease: Data from 2000 to 2019
|Cell Metabolism|2023|777